Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bieke Lambert

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Canadian Journal of Physiology and Pharmacology|January 16, 2007
Assessment of supra-additive effects of cytotoxic drugs and low dose rate irradiation in an in vitro model for hepatocellular carcinomaBieke Lambert, Leo De Ridder, Filip De Vos, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2005
Radiolabeled lipiodol therapy for hepatocellular carcinoma in patients awaiting liver transplantation: pathology of the explant livers and clinical outcomeBieke Lambert, Marleen Praet, Peter Vanlangenhove, et al.
RMD Open|July 13, 2016
Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritisPhilippe Carron, Bieke Lambert, Liesbet Van Praet, et al.
Journal of Medical Imaging and Radiation Oncology|August 17, 2016
Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (<sup>18</sup> F-FDG-PET) in the treatment of bone metastases: results from a 3-arm randomized phase II trialDieter Berwouts, Katrien De Wolf, Wilfried De Neve, et al.
Clinical Genitourinary Cancer|September 27, 2012
Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapyPatrick Berkovic, Gert De Meerleer, Louke Delrue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinomaKim De Ruyck, Bieke Lambert, Klaus Bacher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 13, 2012
Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched studyKatrien Vandecasteele, Louke Delrue, Bieke Lambert, et al.
EJNMMI Research|December 14, 2016
<sup>99m</sup>Tc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry studyBieke Lambert, Philippe Carron, Yves D'Asseler, et al.
Radiation Oncology (London, England)|June 13, 2014
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrenceKarel Decaestecker, Gert De Meerleer, Bieke Lambert, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 14, 2018
Hemodynamic changes in ALPPS influence liver regeneration and function: results from a prospective studyFederico Tomassini, Yves D'Asseler, Mariano C Giglio, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Canadian Journal of Physiology and Pharmacology|January 16, 2007
Assessment of supra-additive effects of cytotoxic drugs and low dose rate irradiation in an in vitro model for hepatocellular carcinomaBieke Lambert, Leo De Ridder, Filip De Vos, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2005
Radiolabeled lipiodol therapy for hepatocellular carcinoma in patients awaiting liver transplantation: pathology of the explant livers and clinical outcomeBieke Lambert, Marleen Praet, Peter Vanlangenhove, et al.
RMD Open|July 13, 2016
Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritisPhilippe Carron, Bieke Lambert, Liesbet Van Praet, et al.
Journal of Medical Imaging and Radiation Oncology|August 17, 2016
Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (<sup>18</sup> F-FDG-PET) in the treatment of bone metastases: results from a 3-arm randomized phase II trialDieter Berwouts, Katrien De Wolf, Wilfried De Neve, et al.
Clinical Genitourinary Cancer|September 27, 2012
Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapyPatrick Berkovic, Gert De Meerleer, Louke Delrue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinomaKim De Ruyck, Bieke Lambert, Klaus Bacher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 13, 2012
Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched studyKatrien Vandecasteele, Louke Delrue, Bieke Lambert, et al.
EJNMMI Research|December 14, 2016
<sup>99m</sup>Tc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry studyBieke Lambert, Philippe Carron, Yves D'Asseler, et al.
Radiation Oncology (London, England)|June 13, 2014
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrenceKarel Decaestecker, Gert De Meerleer, Bieke Lambert, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 14, 2018
Hemodynamic changes in ALPPS influence liver regeneration and function: results from a prospective studyFederico Tomassini, Yves D'Asseler, Mariano C Giglio, et al.
Pageof 5